Home/Eolo Pharma/Carlos Escande

CE

Carlos Escande

CSO and Board Member

Therapeutic Areas

Obesity Metabolic Disease Type 2 Diabetes NASH Hypertension ALS Alzheimer's Disease

Eolo Pharma Pipeline

Drug	Indication	Phase
MVD-1 (SANA)	Obesity	Phase 1
Eolo40 NCE	ALS	Discovery
NF-kB inhibitor	Alzheimer's Disease	Discovery

Leadership Team at Eolo Pharma

María Pia Garat

Carlos Batthyany

View full Eolo Pharma profile